241 related articles for article (PubMed ID: 26455267)
1. Impact of cathepsin B on the interstitial fluid proteome of murine breast cancers.
Gomez-Auli A; Hillebrand LE; Biniossek ML; Peters C; Reinheckel T; Schilling O
Biochimie; 2016 Mar; 122():88-98. PubMed ID: 26455267
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.
Vasiljeva O; Papazoglou A; Krüger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T
Cancer Res; 2006 May; 66(10):5242-50. PubMed ID: 16707449
[TBL] [Abstract][Full Text] [Related]
3. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.
Bengsch F; Buck A; Günther SC; Seiz JR; Tacke M; Pfeifer D; von Elverfeldt D; Sevenich L; Hillebrand LE; Kern U; Sameni M; Peters C; Sloane BF; Reinheckel T
Oncogene; 2014 Sep; 33(36):4474-84. PubMed ID: 24077280
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice.
Sevenich L; Werner F; Gajda M; Schurigt U; Sieber C; Müller S; Follo M; Peters C; Reinheckel T
Oncogene; 2011 Jan; 30(1):54-64. PubMed ID: 20818432
[TBL] [Abstract][Full Text] [Related]
5. Deletion of cysteine cathepsins B or L yields differential impacts on murine skin proteome and degradome.
Tholen S; Biniossek ML; Gansz M; Gomez-Auli A; Bengsch F; Noel A; Kizhakkedathu JN; Boerries M; Busch H; Reinheckel T; Schilling O
Mol Cell Proteomics; 2013 Mar; 12(3):611-25. PubMed ID: 23233448
[TBL] [Abstract][Full Text] [Related]
6. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.
Greening DW; Kapp EA; Ji H; Speed TP; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2396-407. PubMed ID: 23684732
[TBL] [Abstract][Full Text] [Related]
7. The secreted inhibitor of invasive cell growth CREG1 is negatively regulated by cathepsin proteases.
Gomez-Auli A; Hillebrand LE; Christen D; Günther SC; Biniossek ML; Peters C; Schilling O; Reinheckel T
Cell Mol Life Sci; 2021 Jan; 78(2):733-755. PubMed ID: 32385587
[TBL] [Abstract][Full Text] [Related]
8. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
[TBL] [Abstract][Full Text] [Related]
10. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of silenced cathepsin B expression suggests non-proteolytic cathepsin B functionality.
Sigloch FC; Knopf JD; Weißer J; Gomez-Auli A; Biniossek ML; Petrera A; Schilling O
Biochim Biophys Acta; 2016 Nov; 1863(11):2700-2709. PubMed ID: 27526672
[TBL] [Abstract][Full Text] [Related]
12. Proteomic Profiling of Cardiomyocyte-Specific Cathepsin A Overexpression Links Cathepsin A to the Oxidative Stress Response.
Petrera A; Kern U; Linz D; Gomez-Auli A; Hohl M; Gassenhuber J; Sadowski T; Schilling O
J Proteome Res; 2016 Sep; 15(9):3188-95. PubMed ID: 27432266
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.
Sevenich L; Schurigt U; Sachse K; Gajda M; Werner F; Müller S; Vasiljeva O; Schwinde A; Klemm N; Deussing J; Peters C; Reinheckel T
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2497-502. PubMed ID: 20133781
[TBL] [Abstract][Full Text] [Related]
14. Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.
Tholen S; Biniossek ML; Gansz M; Ahrens TD; Schlimpert M; Kizhakkedathu JN; Reinheckel T; Schilling O
Cell Mol Life Sci; 2014 Mar; 71(5):899-916. PubMed ID: 23811845
[TBL] [Abstract][Full Text] [Related]
15. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
[TBL] [Abstract][Full Text] [Related]
16. Contribution of cathepsin L to secretome composition and cleavage pattern of mouse embryonic fibroblasts.
Tholen S; Biniossek ML; Gessler AL; Müller S; Weisser J; Kizhakkedathu JN; Reinheckel T; Schilling O
Biol Chem; 2011 Nov; 392(11):961-71. PubMed ID: 21972973
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells.
Sobotič B; Vizovišek M; Vidmar R; Van Damme P; Gocheva V; Joyce JA; Gevaert K; Turk V; Turk B; Fonović M
Mol Cell Proteomics; 2015 Aug; 14(8):2213-28. PubMed ID: 26081835
[TBL] [Abstract][Full Text] [Related]
18. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells.
Lee MJ; Kim J; Kim MY; Bae YS; Ryu SH; Lee TG; Kim JH
J Proteome Res; 2010 Apr; 9(4):1754-62. PubMed ID: 20184379
[TBL] [Abstract][Full Text] [Related]
20. TAILS N-Terminomics and Proteomics Show Protein Degradation Dominates over Proteolytic Processing by Cathepsins in Pancreatic Tumors.
Prudova A; Gocheva V; Auf dem Keller U; Eckhard U; Olson OC; Akkari L; Butler GS; Fortelny N; Lange PF; Mark JC; Joyce JA; Overall CM
Cell Rep; 2016 Aug; 16(6):1762-1773. PubMed ID: 27477282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
